Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Intelligent Bio Solutions Inc. (INBS : NSDQ)

• Company Description    Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK. Number of Employees: 14

• Price / Volume Information    Yesterday's Closing Price: $5.02 Daily Weekly Monthly 20 Day Moving Average: 124,923 shares Shares Outstanding: 1.60 (millions) Market Capitalization: $8.05 (millions) Beta: 4.48 52 Week High: $27.50 52 Week Low: $4.03 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -65.62% -65.09% 12 Week -25.83% -28.36% Year To Date -47.32% -47.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 135 W 41ST ST FLOOR 5 - NEW YORK,NY 10036 USA ph: 646-828-8258 fax: - inbs@kcsa.com https://ibs.inc

• General Corporate Information    Officers Harry Simeonidis - Chief Executive Officer and President Steven Boyages - Chairman of the Board Spiro Sakiris - Chief Financial Officer Jonathan Hurd - Director Jason Isenberg - Director Peer Information Intelligent Bio Solutions Inc. (CHCR) Intelligent Bio Solutions Inc. (ESRX) Intelligent Bio Solutions Inc. (MYDP) Intelligent Bio Solutions Inc. (COR) Intelligent Bio Solutions Inc. (GBCS) Intelligent Bio Solutions Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 36151G709 SIC: 3841 Fiscal Year Fiscal Year End: June Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/12/26 Share - Related Items Shares Outstanding: 1.60 Most Recent Split Date: 12.00 (0.10:1) Beta: 4.48 Market Capitalization: $8.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.50 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/12/26

• Fundamental Ratios P/E Current FY Estimate: 1.43 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.56 Price/Cash Flow: - Price / Sales: 2.25 EPS Growth vs. Year Ago Period: 43.60% vs. Previous Quarter: 19.43% Sales Growth vs. Year Ago Period: 47.53% vs. Previous Quarter: -19.33% ROE 12/31/25 - -200.68 09/30/25 - -276.73 06/30/25 - -231.13 ROA 12/31/25 - -97.31 09/30/25 - -116.49 06/30/25 - -108.24 Current Ratio 12/31/25 - 2.37 09/30/25 - 0.89 06/30/25 - 0.77 Quick Ratio 12/31/25 - 2.26 09/30/25 - 0.76 06/30/25 - 0.65 Operating Margin 12/31/25 - -309.18 09/30/25 - -323.29 06/30/25 - -338.98 Net Margin 12/31/25 - -315.33 09/30/25 - -330.00 06/30/25 - -346.22 Pre-Tax Margin 12/31/25 - -316.44 09/30/25 - -331.16 06/30/25 - -347.36 Book Value 12/31/25 - 8.95 09/30/25 - 3.78 06/30/25 - 4.07 Inventory Turnover 12/31/25 - 3.04 09/30/25 - 2.83 06/30/25 - 2.62 Debt-to-Equity 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©